Argonaute-2 Antibody

About the Target

AGO2 (Argonaute-2), also known as EIF2C2, is a member of the highly conserved Argonaute family, characterized by the presence of the PIWI domain and the crescent PAZ domain. Within the human Argonaute family, AGO2 belongs to the AGO subfamily, alongside AGO1, AGO3, and AGO4, sharing similarities with Arabidopsis thaliana AGO1. Depending on the literature source, EIF2C2 may also be discussed as Argonaute-2 and AGO2.

Reported cellular context includes cytoplasm and nucleus, which can matter when signal is compared across treatments or changing cell states. Following EIF2C2 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

EIF2C2 is commonly interpreted in the context of cancer research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm and nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cytoplasm and nucleus across matched conditions
• changes associated with proliferative state, oncogenic signaling, or treatment response
• co-patterning with orthogonal markers and control conditions that clarify pathway state
• time-matched comparisons so changes reflect biology rather than handling or sampling drift

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for EIF2C2. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in EIF2C2 reflect biology rather than handling. When interpreting EIF2C2, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep EIF2C2 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.